Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03205150
What this trial is testing

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

Who this might be right for
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 107
Large-scale testing (Phase 3)Study completedNCT02098317
What this trial is testing

DHA and Vitamin D in Children With Biopsy-proven NAFLD

Who this might be right for
NAFLDNon Alcoholic Steatohepatitis (NASH)
Bambino Gesù Hospital and Research Institute 66
Early research (Phase 1)Looking for participantsNCT07726368
What this trial is testing

Study of ECC4703 With Sulfasalazine and Pitavastatin

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Dyslipidaemia
Eccogene 40
Early research (Phase 1)Study completedNCT04483947
What this trial is testing

Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
AstraZeneca 74
Not applicableLooking for participantsNCT06571474
What this trial is testing

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

Who this might be right for
ObesityNon-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2+1 more
Bettina Mittendorfer 60
Not applicableEnrolling By InvitationNCT06895018
What this trial is testing

Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Federico II University 20
Early research (Phase 1)Study completedNCT04844450
What this trial is testing

A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795

Who this might be right for
Fatty Liver Disease
Janssen Research & Development, LLC 55
Not applicableStudy completedNCT04782050
What this trial is testing

Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation

Who this might be right for
Liver DiseasesLiver CirrhosisNon-Alcoholic Fatty Liver Disease
E-Scopics 100
Early research (Phase 1)Study completedNCT04142424
What this trial is testing

Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Who this might be right for
Metabolic DisordersNon-alcoholic Steatohepatitis
AstraZeneca 73
Not applicableNot Yet RecruitingNCT07793279
What this trial is testing

Hypothyroidism and Liver Fibrosis Severity in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHypothyroidismLiver Cirrhosis+1 more
Assiut University 85
Large-scale testing (Phase 3)Study completedNCT00063622
What this trial is testing

Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)

Who this might be right for
Liver Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 247
Testing effectiveness (Phase 2)Study completedNCT05591079
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Cascade Pharmaceuticals, Inc 99
Testing effectiveness (Phase 2)Study completedNCT04929483
What this trial is testing

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 222
Not applicableUnknownNCT05960396
What this trial is testing

Exploring the Mechanism of Dietary Pattern Improving MAFLD

Who this might be right for
NAFLDDiet Habit
Second Affiliated Hospital, Zhejiang University, School of Medicine 80
Early research (Phase 1)Study completedNCT06308861
What this trial is testing

Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males

Who this might be right for
Non-alcoholic Steatohepatitis
J2H Biotech 100
Not applicableStudy completedNCT04435054
What this trial is testing

Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hospices Civils de Lyon 1,000
Early research (Phase 1)Study completedNCT04722653
What this trial is testing

A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men

Who this might be right for
Non-alcoholic Steatohepatitis
Novo Nordisk A/S 42
Not applicableUnknownNCT05029583
What this trial is testing

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Who this might be right for
Nonalcoholic SteatohepatitisType 2 Diabetes
LMC Diabetes & Endocrinology Ltd. 5,000
Not applicableLooking for participantsNCT02206841
What this trial is testing

Establishment of NAFLD Cohort and Development of Fibrosis Markers

Who this might be right for
Fibrosis of Liver
Seoul National University Boramae Hospital 1,000
Not applicableUnknownNCT05220956
What this trial is testing

Impact of Time-restricted Feeding in NAFLD

Who this might be right for
Fatty Liver DiseaseFatty LiverFatty Liver, Nonalcoholic
Johannes Gutenberg University Mainz 100
Next Page